Intravascular coagulation-fibrinolysis (ICF) syndrome and malignancy: historical review and report of two cases with metastatic carcinoid and with acute myelomonocytic leukemia.
D000328:Adult; D000347:Afibrinogenemia; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology* / Q000266:history / Q000628:therapy; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D001803:Blood Transfusion; D002276:Carcinoid Tumor / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005340:Fibrinogen / Q000032:analysis / Q000627:therapeutic use; D005342:Fibrinolysis; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000628:therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D008937:Mitomycins; D013256:Steroids; D005340:Fibrinogen; D015122:Mercaptopurine; D011241:Prednisone